Newer ERAs have since been designed that preferentially target endothelin A receptors, associated with inflammation and podocytopathy, over endothelin B receptors, associated with vasodilation and natriuresis [74]
Curr Diabetes Rev 14(3):273279 Mousavi A et al (2025) Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Initial research has found that these medications may improve outcomes in people with conditions ranging from sleep apnea and fatty liver disease to heart and kidney disease
tirzepatide There are two new heavyweights (
Not for use by persons under the age of 18
Moreover, 18.9% of patients in the GLP1-RAs group required a repeat colonoscopy due to poor bowel preparation, compared to 11.1% of the controls ( p -value 0.041) [28]